-
1.
公开(公告)号:US06339069B1
公开(公告)日:2002-01-15
申请号:US09343650
申请日:1999-06-29
申请人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly , Patrick L. Ahl
发明人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly , Patrick L. Ahl
IPC分类号: A61K4800
CPC分类号: A61K9/127 , A61K9/1271 , A61K9/1272 , A61K9/1275 , A61K38/00 , A61K47/543 , A61K47/544 , A61K47/6911 , C07K1/1077 , C07K5/06026 , C07K5/06191 , C07K5/0806 , C07K5/0808 , C07K5/0819 , C07K5/0823 , C07K5/0827 , C07K5/1008 , C07K5/1013 , C07K5/1027 , C07K7/06 , C07K9/001
摘要: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
摘要翻译: 将肽 - 脂质缀合物掺入脂质体中,以选择性地使目标肽酶分泌细胞附近的脂质体不稳定,从而将脂质体递送至靶细胞附近或直接进入细胞。 因此,脂质体可用于治疗哺乳动物疾病,病症或病症,例如肿瘤,微生物感染和炎症,其特征在于发生肽酶分泌细胞。
-
公开(公告)号:US6143716A
公开(公告)日:2000-11-07
申请号:US168010
申请日:1998-10-07
申请人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly
发明人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly
IPC分类号: A61K9/127 , A61K38/00 , A61K47/48 , C07K1/107 , C07K5/06 , C07K5/08 , C07K5/083 , C07K5/093 , C07K5/097 , C07K5/10 , C07K5/103 , C07K7/06 , C07K9/00 , C07K5/00 , C07K7/00
CPC分类号: C07K7/06 , A61K47/48053 , A61K47/48238 , A61K47/48815 , A61K9/127 , A61K9/1271 , A61K9/1272 , C07K1/1077 , C07K5/06026 , C07K5/06191 , C07K5/0806 , C07K5/0808 , C07K5/0819 , C07K5/0823 , C07K5/0827 , C07K5/1008 , C07K5/1013 , C07K5/1027 , C07K9/001 , A61K38/00
摘要: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
摘要翻译: 将肽 - 脂质缀合物掺入脂质体中,以选择性地使目标肽酶分泌细胞附近的脂质体不稳定,从而将脂质体递送至靶细胞附近或直接进入细胞。 因此,脂质体可用于治疗哺乳动物疾病,病症或病症,例如肿瘤,微生物感染和炎症,其特征在于发生肽酶分泌细胞。
-
公开(公告)号:US6087325A
公开(公告)日:2000-07-11
申请号:US950618
申请日:1997-10-15
申请人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly
发明人: Paul R. Meers , Charles Pak , Shaukat Ali , Andrew Janoff , J. Craig Franklin , Ravi K. Erukulla , Donna Cabral-Lilly
IPC分类号: A61K9/127 , A61K38/00 , A61K47/48 , C07K1/107 , C07K5/06 , C07K5/08 , C07K5/083 , C07K5/093 , C07K5/097 , C07K5/10 , C07K5/103 , C07K7/06 , C07K9/00 , C07K5/00 , C07K7/00
CPC分类号: C07K7/06 , A61K47/48053 , A61K47/48238 , A61K47/48815 , A61K9/127 , A61K9/1271 , A61K9/1272 , C07K1/1077 , C07K5/06026 , C07K5/06191 , C07K5/0806 , C07K5/0808 , C07K5/0819 , C07K5/0823 , C07K5/0827 , C07K5/1008 , C07K5/1013 , C07K5/1027 , C07K9/001 , A61K38/00
摘要: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
摘要翻译: 将肽 - 脂质缀合物掺入脂质体中,以选择性地使目标肽酶分泌细胞附近的脂质体不稳定,从而将脂质体递送至靶细胞附近或直接进入细胞。 因此,脂质体可用于治疗哺乳动物疾病,病症或病症,例如肿瘤,微生物感染和炎症,其特征在于发生肽酶分泌细胞。
-
公开(公告)号:US07060291B1
公开(公告)日:2006-06-13
申请号:US10130951
申请日:2000-11-17
申请人: Paul R. Meers , Tong Shangguan , Donna Cabral-Lilly , Patrick Ahl , Ravi Erukulla , Andrew Janoff
发明人: Paul R. Meers , Tong Shangguan , Donna Cabral-Lilly , Patrick Ahl , Ravi Erukulla , Andrew Janoff
IPC分类号: A61K9/127
CPC分类号: A61K9/1271
摘要: A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.
-
公开(公告)号:US07491409B1
公开(公告)日:2009-02-17
申请号:US09914615
申请日:2000-03-01
IPC分类号: A61K9/127
CPC分类号: A61K9/1272 , A61K9/127
摘要: This invention provides a method to prepare liposome-encapsulated bioactive agents such as nucleic acids, comprising complexation of the bioactive agents in reverse micelles prior to forming liposomes, as well as methods of using the liposomes so formed and formulations to deliver nucleic acids to cells.
摘要翻译: 本发明提供了一种制备脂质体包封的生物活性剂如核酸的方法,其包括在形成脂质体之前在反胶束中络合生物活性剂,以及使用如此形成的脂质体和制剂将核酸递送至细胞的方法。
-
公开(公告)号:US20060172003A1
公开(公告)日:2006-08-03
申请号:US11359964
申请日:2006-02-22
申请人: Paul Meers , Tong Shangguan , Donna Cabral-Lilly , Patrick Ahl , Ravi Erukulla , Andrew Janoff
发明人: Paul Meers , Tong Shangguan , Donna Cabral-Lilly , Patrick Ahl , Ravi Erukulla , Andrew Janoff
IPC分类号: A61K9/127
CPC分类号: A61K9/1271
摘要: A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.
摘要翻译: 包括融合脂质体,连接部分和靶向部分的脂质体。 融合脂质体是封装内容物的脂双层。 连接部分与脂质双层静电结合,靶向部分与连接部分共价结合。 脂质体还可以包括置于连接部分和靶向部分之间的共价结合两者的稳定部分。 或者,稳定化和靶向部分可以共价结合到分离的连接部分,连接部分被静电结合到脂质双层。
-
公开(公告)号:US20090068256A1
公开(公告)日:2009-03-12
申请号:US12197794
申请日:2008-08-25
申请人: Paul Meers , Tong Shangguan , Donna Cabral-Lilly , Andrew Janoff , Patrick Ahl
发明人: Paul Meers , Tong Shangguan , Donna Cabral-Lilly , Andrew Janoff , Patrick Ahl
IPC分类号: A61K9/127 , A61K31/7052 , A61P43/00
CPC分类号: A61K9/1272 , A61K9/127
摘要: This invention provides a method to prepare liposome-encapsulated bioactive agents, such as nucleic acids, comprising complexation of the bioactive agents to reverse micelles prior to forming liposomes, as well as methods of using the liposomes so formed and formulations to deliver nucleic acids to cells.
摘要翻译: 本发明提供了制备脂质体包封的生物活性剂(例如核酸)的方法,其包括在形成脂质体之前将生物活性剂与反胶束的络合,以及使用如此形成的脂质体的方法和制剂将核酸递送至细胞 。
-
公开(公告)号:US20090098196A1
公开(公告)日:2009-04-16
申请号:US11813958
申请日:2006-01-26
申请人: Paul Tardi , Lawrence Mayer , Donna Cabral-Lilly
发明人: Paul Tardi , Lawrence Mayer , Donna Cabral-Lilly
IPC分类号: A61K9/127
CPC分类号: A61K9/127 , A61K9/1277
摘要: The invention relates to a method for reducing the polydispersity of a population of gel-phase lipid-based delivery vehicles.
摘要翻译: 本发明涉及降低凝胶相脂质递送载体群体的多分散性的方法。
-
-
-
-
-
-
-